STOCK TITAN

Nascent Biotech (NBIO) Debt by Year

NBIO OTC

Nascent Biotech Inc held $372K in cash and equivalents at the end of fiscal year 2024, and no long-term debt figure is on record for that period. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Nascent Biotech Inc has filed alongside them.

FY2024 annual
Long-Term Debt N/A
Cash & Equivalents $372K
Source SEC Filings Latest period Q1 FY2025, ended Jun 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NBIO Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18FilingFY17FilingFY16FilingFY15FilingFY14Filing
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$372K+116.1%$172K+82.4%$94K+6484.0%$1K-55.4%$3K-97.6%$131K+12.4%$117K-9.9%$130K-77.4%$573K+433.0%$108K-5.5%$114K

NBIO Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22Filing
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$47K+399.9%$372K+116.1%$624K+11.6%$1.0M-15.1%$9K-93.5%$172K+82.4%$559K+32068.3%$1.2M+1054.4%$146K-45.9%$94K+6484.0%$2K-96.8%$102K+3.2%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Nascent Biotech Inc financials

Frequently Asked Questions

Nascent Biotech Inc held $372K in cash and equivalents at the end of fiscal year 2024, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Nascent Biotech Inc (NBIO) reported on that line in every period on record.